Eli Lilly and Company has shown rapid growth with significant revenue increases. Click here to find out why I've decided to ...

Grassi Investment Management lessened its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 0.2% in the ...

Romano Brothers AND Company raised its stake in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.7% in the 3rd quarter, ...

Eli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

The company is suing some online vendors and medical spas for selling copycats of a weight loss and diabetes drug.

A new class of weight-loss drugs is changing the food industry, but not in the way many expected at first. They could present ...

Eli Lilly LLY.N said on Monday it sued three medical spas and online vendors for selling products claiming to contain ...

Acute Migraine Treatment MarketThe global migraine treatment market is anticipated to achieve a valuation of USD 3.2 billion ...

Global Gene Therapy in CNS Disorder IndustryThe global gene therapy market for central nervous system (CNS) disorders is set ...

Lilly will launch its Mounjaro obesity drug in Denmark next week, the U.S. drugmaker said on Thursday, bringing competition ...

As the demand for weight loss injectables soars, so too does the market for off-brand alternatives, some of which may not be ...